BioVaxys Technology's total assets for Q1 2025 were C$1.28M, a decrease of -1.50% from the previous quarter. BVAXF total liabilities were C$3.02M for the fiscal quarter, a -6.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.